argenx Announces Approval of VYVGART (efgartigimod alfa) in
VYVGART® now approved in Japan for both generalized myasthenia gravis and primary immune thrombocytopenia (ITP) Regulatory decision in Japan represents...
Source: globenewswire.com
Argenx Se News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Argenx Se. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Argenx Se Today - Breaking & Trending Today
Healthcare Stocks Are Priced for a Fire Sale. These 6 Funds Can Ride Them Higher.
Actively managed mutual funds make sense when investing in healthcare, since companies’ future prospects are often difficult for the market to price...
Source: marketwatch.com
Morgan Stanley likes biopharma as defensive play, shares stock picks
The sector offers a safe haven from macroeconomic and earnings concerns ahead of quarterly results from European companies, according to the Wall Street bank.
Source: cnbc.com
European markets live updates: stocks, news and data
European stocks opened lower Friday, extending mild losses even after U.S. stocks strongly rebounded from their worst session in months.
Source: cnbc.com
Argenx stock dives by a third after late-stage trial didn't meet goals
Argenx stock lost a third of its value as the Amsterdam biotech said a late-stage trial did not meet primary or secondary endpoints. The Phase 3 study was of...
Source: marketwatch.com